Abstract
Sporadic cancer develops approximately at 65 years of age. Epidemiologic data suggest that dietary factors probably are the most influential in colorectal carcinogenesis. In contrast, individuals who have relatives with colorectal neoplasia have an increased risk of these tumors themselves, which will appear earlier in life. The actual incidence of hereditary colorectal cancer is unknown. However, the incidence is much higher compared with well-known hereditary colorectal diseases, such as familial adenomatous polyposis. OBJECTIVE: An overview of the recent progress in the field of both clinical and basic research on hereditary colorectal cancer must be made. MATERIALS AND METHODS: Twenty-two family pedigrees were analyzed at Hamamatsu University School of Medicine, including the largest family pedigree in Japan, which contained 24 cases of colorectal cancer occurring over five generations. In 1995, when the International Symposium on Hereditary Cancer was held in Hamamatsu, 4,109 family pedigrees were investigated and analyzed, including 394 cases in 109 family pedigrees that met the Amsterdam Minimum Criteria. Information was collected by sending questionnaires to major hospitals in Japan. Basic updated data presented at the eighth and ninth International Collaborative Group on Hereditary Colorectal Cancer were also quoted. RESULTS AND CONCLUSIONS: Because of the discovery of mismatch repair genes as that responsible for hereditary nonpolyposis colorectal cancer, modification of the Amsterdam Criteria is necessary. Replication error, as a mutator phenotype of mismatch repair genes, is a useful predictor of second primary malignancies. Surveillance or prophylactic surgery is still a controversial issue.
Similar content being viewed by others
References
Warthin AS. Hereditary with reference to carcinoma. Arch Intern Med 1913;12:546–55.
Warthin AS. The further study of a cancer family. J Cancer Res 1925;9:270–86.
Warthin AS. Hereditary of carcinoma in man. Ann Intern Med 1931;4:681–96.
Hauser IJ, Weller CV. A further report on the cancer family of Warthin. Am J Cancer 1936;27:434–44.
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ. Hereditary factors in cancer: study of two large midwestern kindreds. Arch Intern Med 1966;117:206–12.
Lynch HT, Krush AJ. Cancer family G revised: 1895–1970. Cancer 1971;27:1505–11.
Boland CR, Troncale FJ. Familial colonic cancer without antecedent polyposis. Ann Intern Med 1984;100:700–1.
Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995;87:1114–25.
Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancers (Lynch syndrome): an updated review. Cancer 1996;78:1150–67.
Weissenbach J, Gyapay G, Dib C,et al. A second-generation linkage map of the human genome. Nature 1992;359:794–801.
Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558–61.
Aaltonen LA, Peltomaki P, Leach FS,et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812–6.
Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:812–6.
Fishel R, Lescoe MK, Rao MRS,et al. The human mutator gene homologMSH2 and its association with hereditary non-polyposis colon cancer. Cell 1993;75:1027–38.
Leach FS, Nicolaides NC, Papadopoulos N,et al. Mutations of a mutS homolog in hereditary non-polyposis colorectal cancer. Cell 1993;75:1215–25.
Papadopoulos N, Nocolaides NC, Wei YF,et al. Mutation of amutL homolog in hereditary colon cancer. Science 1994;263:1625–9.
Bronner CE, Baker SM, Morrison PT,et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 1994;368:258–61.
Nicolaides NC, Papadopoulos N, Liu B,et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75–80.
Papadopoulos N, Nicolaides NC, Liu B,et al. Mutations of GTBP in genetically unstable cells. Science 1995;268:1915–23.
Liu B, Parsons R, Papadopoulos N,et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Med 1996;2:169–73.
Lothe RA, Peltomaki P, Meling GI,et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993;53:5849–52.
Baba S, ed. New stategies for treatment of hereditary colorectal cancer. Tokyo: Churchill Livingstone, 1996:137–52.
Kawakami K, Yasutomi M, Baba S. Analysis of the HNPCC registries data reported at the 43rd Japanese Society for Cancer of the Colon and Rectum (JSCCR) meeting. In: Baba S, ed. New stategies for treatment of hereditary colorectal cancer. Tokyo: Churchill Livingstone, 1996:229–33.
Spirio L, Olschwang S, Groden J,et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993;75:951–7.
Nystrom-Lahti M, Kristo P, Nicolaides NC,et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nature Med 1995;1:1203–6.
Nystrom-Lahti M, Sistonen P, Mecklin JP,et al. Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families. Proc Natl Acad Sci U S A 1994;91:6054–8.
Buerstedde JM, Alday P, Torhorst J, Weber W, Muller YH, Scott R. Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the hMSH-2 and hMLH-1 genes. J Med Genet 1995;32:909–12.
Han HJ, Maruyama M, Baba S, Park JG, Nakamura Y. Genomic structure of human mismatch repair gene, hMLH-1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC). Hum Mol Genet 1995;4:237–42.
Miyaki M, Konishi M, Muraoka M,et al. Germ line mutations of hMSH-2 and hMLH-1 genes in Japanese families with hereditary nonpolyposis colorectal cancer (HNPCC): usefulness of DNA analysis for screening and diagnosis of HNPCC patients. J Mol Med 1995;73:515–20.
Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative group on hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 1991;34:424–5.
Vasen HF, Wijnen J, Menko FH,et al. Cancer risk in families with hereditary non-polyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020–7.
Hamilton SR, Liu B, Parsons RE,et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839–47.
Lynch HT, Smyrk TC, Watson P,et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535–49.
Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995;64:430–3.
Boland CR. Roles of the DNA mismatch repair genes in colorectal tumorigenesis. Int J Cancer 1996;69:47–9.
Konishi M, Kikuchi-Yanoshita R, Tanaka K,et al. Molecular nature of colon tumors in heriditary nonpolyposis colon cancer, familial polyposis and sporadic colon cancer. Gastroenterology 1996;111:307–17.
Markowitz S, Wang J, Myeroff L,et al. Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336–8.
Rampino N, Yamamoto H, Inovo Y,et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967–96.
Vogelstein B, Fearon ER, Hamilton SR,et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525–32.
Mecklin JP. Frequency of hereditary colorectal carcinonoma. Gastroenterology 1987;93:1021–5.
Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994;14:1631–4.
Jass JR, Pokos V, Arnold JL,et al. Colorectal neoplasms detected colonoscopically in at-risk members of colorectal cancer families stratified by the demonstration of DNA microsatellite instability. J Mol Med 1996;74:547–51.
Albano WA, Lynch HT, Recabaren JA,et al. Familial cancer in an oncology clinic. Cancer 1981;47:2113–8.
Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients withMLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682–7.
Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorgenesis that persists after transformation. Nat Genet 1994;6:273–81.
Fraser FC. Genetic counseling. Am J Hum Genet 1974;26:636–61.
Smith KR, Croyle RT. Attitudes toward genetic testing for colon cancer risk. Am J Public Health 1995;85:1435–8.
Allen JL. Molecular biology of colorectal cancer: clinician's view. Perspect Colon Rectal Surg 1995;8:181–202.
Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary non-polyposis colorectal cancer. Gastroenterelogy 1995;108:1405–11.
Vasen HF, Nagengast FM, Khan PM. Interval cancers in hereditary nonpolyposis colorectal cancer (Lynch syndrome) [letter]. Lancet 1995;345:1183–4.
Dunlop MG, Farrington SM, Carothers AD,et al. Cancer risk associated with germ-line DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105–10.
Burke W, Petersen G, Lynch P,et al. Recommendations follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Study Consortium. JAMA 1997;277:915–9.
Rodriguez-Bigas MA. Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer: Has the time come? Cancer 1996;78:199–201.
Author information
Authors and Affiliations
About this article
Cite this article
Baba, S. Hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 40 (Suppl 10), S86–S95 (1997). https://doi.org/10.1007/BF02062027
Issue Date:
DOI: https://doi.org/10.1007/BF02062027